Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New research from our Department has raised the possibility of minimising the side effects of treatment for patients with autoimmune diseases, such as multiple sclerosis and inflammatory bowel disease.

Molecules

Professor Lars Fugger and his team have been using genetics to explore ways of producing new treatments for autoimmune diseases, but with significantly fewer side effects.

Many of the current treatments for autoimmune diseases, which include multiple sclerosis, rheumatoid arthritis and inflammatory bowel disease, involve deliberately weakening the body’s immune system. This leaves patients at greater risk of developing other opportunistic illnesses.

Read more on the University website...

Similar stories

Heidi Johansen-Berg elected a Fellow of the Royal Society

Professor Heidi Johansen-Berg, Professor of Cognitive Neuroscience has been honoured by the Royal Society by being elected a Fellow for her outstanding contributions to science.